Xenia Geeraerts

Vrije Universiteit Brussel

Belgium

Research Interests

Explore related searches

Professors in Belgium Professors in Immunology Immunology professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (5)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2021

Collaborators (15)

Damya Laoui

Vrije Universiteit Brussel

BELGIUM

View details

JENS TIJTGAT

Vrije Universiteit Brussel

BELGIUM

View details

Manon Vounckx

Vrije Universiteit Brussel

BELGIUM

View details

Pauline Bardet

Vrije Universiteit Brussel

BELGIUM

View details

Yvon Elkrim

Vrije Universiteit Brussel

BELGIUM

View details

Sandra Tuyaerts

Vrije Universiteit Brussel

BELGIUM

View details

Bart Ilsen

Vrije Universiteit Brussel

BELGIUM

View details

Aleksandar Murgaski

Vrije Universiteit Brussel

BELGIUM

View details

Emile Joseph Clappaert

Vrije Universiteit Brussel

BELGIUM

View details

Ramses Forsyth

Vrije Universiteit Brussel

BELGIUM

View details

Benoit Stijlemans

Vrije Universiteit Brussel

BELGIUM

View details

Anne-Marie Vanbinst

Vrije Universiteit Brussel

BELGIUM

View details

Karolien Vekens

Vrije Universiteit Brussel

BELGIUM

View details

Bart Neyns

Vrije Universiteit Brussel

BELGIUM

View details

Ben Caljon

Vrije Universiteit Brussel

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Xenia Geeraerts

Research Interests

Explore related searches

Contact this professor

Articles (5)

A randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells in solid tumors

Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma

Intracranial administration of anti-PD-1 and anti-CTLA-4 immune checkpoint-blocking monoclonal antibodies in patients with recurrent high-grade glioma

Current "state of the art" on dendritic cell-based cancer vaccines in melanoma

Macrophages are metabolically heterogeneous within the tumor microenvironment

Collaborators (15)

Damya Laoui

JENS TIJTGAT

Manon Vounckx

Pauline Bardet

Yvon Elkrim

Sandra Tuyaerts

Bart Ilsen

Aleksandar Murgaski

Emile Joseph Clappaert

Ramses Forsyth

Benoit Stijlemans

Anne-Marie Vanbinst

Karolien Vekens

Bart Neyns

Ben Caljon

Make your next move.